Dr. Jonathan Knowles - Immunocore
Immunocore - a UK-based biotech firm who has licensed its antibody tech to a number of Big Pharma firms this year - has appointed Dr. Jonathan Knowles as its new Chairman of the Board.
Knowles has been a Non-Executive Director of Immunocore since 2010 and has previously served at rohce, Genentech, Chugai Pharmaceuticals and Glaxo Wellcome Europe.
“We are extremely fortunate to have appointed someone of Jonathan’s calibre as the Executive Chairman of the Immunocore Board,” said CEO James Noble. “His significant industry experience will support Immunocore as we continue to build our ImmTAC product pipeline and seek further partnerships with pharmaceutical companies.”
